Germany debates gene patents

Lawmakers introduce a bill to grant commercial rights on genes but allow research use

Ned Stafford(scientistnews@yahoo.com)
Mar 18, 2004

A law has been introduced in Germany's Bundestag, or lower house of parliament, that would make it easier for researchers and companies to obtain patents in the field of biotechnology and would finally bring Germany into compliance with a European Directive issued in 1998.

The bill, which was given a first reading last week (March 11) in the Bundestag, was introduced by Chancellor Gerhard Schroeder';s ruling coalition of the Social Democrat and Green parties. It would grant commercial rights for gene sequences but allow scientists free use of those patented sequences for research purposes.

“It is an improvement on the present state of the law,” Joseph Straus, managing director of the Max Planck Institute for Intellectual Property, Competition and Tax Law, told The Scientist, “and it would bring Germany in line with EU guidelines.”

He said a declaration calling for a new patent law, made early last year, would...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?